Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Loxo Oncology Inc

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : CAPSULE;ORAL

Dosage Strength : 40MG

Packaging :

Approval Date : 2020-05-08

Application Number : 213246

Regulatory Info : RX

Registration Country : USA

blank

02

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : CAPSULE;ORAL

Dosage Strength : 80MG

Packaging :

Approval Date : 2020-05-08

Application Number : 213246

Regulatory Info : RX

Registration Country : USA

blank

03

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : TABLET;ORAL

Dosage Strength : 40MG

Packaging :

Approval Date : 2024-04-10

Application Number : 218160

Regulatory Info : RX

Registration Country : USA

blank

04

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : TABLET;ORAL

Dosage Strength : 80MG

Packaging :

Approval Date : 2024-04-10

Application Number : 218160

Regulatory Info : RX

Registration Country : USA

blank

05

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : TABLET;ORAL

Dosage Strength : 120MG

Packaging :

Approval Date : 2024-04-10

Application Number : 218160

Regulatory Info : RX

Registration Country : USA

blank

06

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : TABLET;ORAL

Dosage Strength : 160MG

Packaging :

Approval Date : 2024-04-10

Application Number : 218160

Regulatory Info : RX

Registration Country : USA

blank

07

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : CAPSULE;ORAL

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number : 218160

Regulatory Info :

Registration Country : USA

blank

08

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : CAPSULE;ORAL

Dosage Strength : 80MG

Packaging :

Approval Date :

Application Number : 218160

Regulatory Info :

Registration Country : USA

blank

09

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : CAPSULE

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number : 2516918

Regulatory Info : Prescription

Registration Country : Canada

blank

10

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

Brand Name : RETEVMO

Dosage Form : CAPSULE

Dosage Strength : 80MG

Packaging :

Approval Date :

Application Number : 2516926

Regulatory Info : Prescription

Registration Country : Canada

blank